IOVA icon

Iovance Biotherapeutics
IOVA

Overview Fund Activity

200 hedge funds and large institutions have $3.44B invested in Iovance Biotherapeutics in 2019 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 75 increasing their positions, 60 reducing their positions, and 13 closing their positions.

Holders
200
Holders Change
+27
Holders Change %
+15.61%
% of All Funds
3.95%
Holding in Top 10
10
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+25%
% of All Funds
0.2%
New
45
Increased
75
Reduced
60
Closed
13
Calls
$62.1M
Puts
$9.22M
Net Calls
+$52.8M
Net Calls Change
+$28M

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$77.6M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$66.5M
3
Norges Bank
3
Norges Bank
Norway
$36.2M
4
Artisan Partners
4
Artisan Partners
Wisconsin
$45.5M
5
EAM
5
Eagle Asset Management
Florida
$9.02M

Top Sellers

1
ACA
1
Avoro Capital Advisors
New York
$244M
2
PA
2
Perceptive Advisors
New York
$261M
3
Franklin Resources
3
Franklin Resources
California
$152M
4
BC
4
Broadfin Capital
New York
$14.8M
5
State Street
5
State Street
Massachusetts
$120M
Name Holding Trade Value Shares
Change 		Shares
Change %
TEE
201
Tibra Equities Europe
United Kingdom
– -$348K -19,100 Closed
CC
202
Centiva Capital
New York
– -$261K -14,341 Closed
ACM
203
AlphaCrest Capital Management
New York
– -$218K -12,000 Closed
VF
204
Virtu Financial
New York
– -$215K -11,814 Closed
QT
205
Quantamental Technologies
New York
– -$106K -5,803 Closed
QT
206
Quantbot Technologies
New York
– -$27K -1,500 Closed
AIC
207
Ameritas Investment Company
Nebraska
– -$1K -60 Closed
FGAM
208
Financial Gravity Asset Management
Texas
– -$1K -33 Closed
5 6 7 8
9